Donald Thompson
Known title: DirectorCIK: 0001374074
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Royal Caribbean Stock Rises 12% as Earnings Outlook Improves. Recent news highlights Royal Caribbean's 12% stock rise over the past month, outperforming the broader market. The company faces questions regarding its expanded Europe lineup and whether it can continue to beat earnings estimates. Industry observers suggest the cruise sector may see calmer waters in upcoming quarters, supporting the recent stock momentum.
Transaction History
| NTRS | ▲ Buy | Grant | 145 | $25K | 10/1/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 221 | $37K | 9/30/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 126 | $22K | 7/1/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 216 | $38K | 6/30/2026 | View on chart |
| RCL | ▼ Sell | Tax Withholding | 78 | $22K | 5/28/2026 | View on chart |
| RCL | ▲ Buy | Grant | 831 | $0 | 5/28/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 35 | $6K | 4/21/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 989 | $0 | 4/21/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 143 | $20K | 4/1/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 269 | $37K | 3/31/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 145 | $20K | 1/1/2026 | View on chart |
| NTRS | ▲ Buy | Grant | 275 | $37K | 12/31/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 149 | $20K | 10/1/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 279 | $37K | 9/30/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 140 | $18K | 7/1/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 293 | $37K | 6/30/2025 | View on chart |
| RCL | ▲ Buy | Grant | 870 | $0 | 5/28/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 61 | $5K | 4/22/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 1,902 | $0 | 4/22/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 165 | $16K | 4/1/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 367 | $36K | 3/31/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 154 | $16K | 1/1/2025 | View on chart |
| NTRS | ▲ Buy | Grant | 354 | $36K | 12/31/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 173 | $15K | 10/1/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 403 | $36K | 9/30/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 178 | $15K | 7/1/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 432 | $36K | 6/30/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 70 | $6K | 4/16/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 1,822 | $0 | 4/16/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 147 | $13K | 4/1/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 408 | $36K | 3/31/2024 | View on chart |
| RCL | ▲ Buy | Grant | 2,372 | $0 | 2/8/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 149 | $13K | 1/1/2024 | View on chart |
| NTRS | ▲ Buy | Grant | 430 | $36K | 12/31/2023 | View on chart |
| NTRS | ▲ Buy | Grant | 174 | $12K | 10/1/2023 | View on chart |
| NTRS | ▲ Buy | Grant | 522 | $36K | 9/30/2023 | View on chart |
| NTRS | ▲ Buy | Grant | 156 | $12K | 7/1/2023 | View on chart |
| NTRS | ▲ Buy | Grant | 489 | $36K | 6/30/2023 | View on chart |
| NTRS | ▲ Buy | Grant | 51 | $4K | 4/25/2023 | View on chart |
| NTRS | ▲ Buy | Grant | 1,855 | $0 | 4/25/2023 | View on chart |
| NTRS | ▲ Buy | Grant | 115 | $10K | 4/1/2023 | View on chart |
| NTRS | ▲ Buy | Grant | 411 | $36K | 3/31/2023 | View on chart |
| RCL | ▲ Buy | Grant | 2,682 | $0 | 2/9/2023 | View on chart |
| NTRS | ▲ Buy | Grant | 110 | $10K | 1/1/2023 | View on chart |
| NTRS | ▲ Buy | Grant | 410 | $36K | 12/31/2022 | View on chart |
| NTRS | ▲ Buy | Grant | 109 | $9K | 10/1/2022 | View on chart |
| NTRS | ▲ Buy | Grant | 424 | $36K | 9/30/2022 | View on chart |
| NTRS | ▲ Buy | Grant | 86 | $8K | 7/1/2022 | View on chart |
| NTRS | ▲ Buy | Grant | 358 | $35K | 6/30/2022 | View on chart |
| NTRS | ▲ Buy | Grant | 30 | $3K | 4/26/2022 | View on chart |
| NTRS | ▲ Buy | Grant | 1,343 | $0 | 4/26/2022 | View on chart |
| NTRS | ▲ Buy | Grant | 64 | $7K | 4/1/2022 | View on chart |
| NTRS | ▲ Buy | Grant | 258 | $30K | 3/31/2022 | View on chart |
| RCL | ▲ Buy | Grant | 2,256 | $0 | 2/10/2022 | View on chart |
| NTRS | ▲ Buy | Grant | 60 | $7K | 1/1/2022 | View on chart |
| NTRS | ▲ Buy | Grant | 251 | $30K | 12/31/2021 | View on chart |
| NTRS | ▲ Buy | Grant | 63 | $7K | 10/1/2021 | View on chart |
| NTRS | ▲ Buy | Grant | 278 | $30K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Northern Trust Q3 Earnings Loom Amid Mixed Sector News
Northern Trust is approaching its third-quarter earnings release, with analysts focusing on revenue and EPS estimates. Recent reports indicate the stock has experienced a sharp decline, joining other financial peers in a downturn. While one firm reaffirmed a positive outlook citing the company's quality, the broader sector remains under pressure.
Northern Trust Q3 Earnings Loom Amid Mixed Sector News. Northern Trust is approaching its third-quarter earnings release, with analysts focusing on revenue and EPS estimates. Recent reports indicate the stock has experienced a sharp decline, joining other financial peers in a downturn. While one firm reaffirmed a positive outlook citing the company's quality, the broader sector remains under pressure.